Leukocyte count predicts severity of COVID-19 symptoms in older women

Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people.

Startup Celsius cuts 75% of staff ahead of first trial start for IBD drug

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO

August 3, 2023

Canada Is Down Not Out

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight

April 19, 2024

Retinal Tumor Risk Incidentally Detected at 29 Weeks’ Gestation

Incidental detection of a genetic abnormality in a fetus at 29 weeks’ gestation was the conundrum facing Ido Didi Fabian, MD, of The Goldschleger Eye

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.